Navigation Links
Masimo Reports Fourth Quarter and Full Year 2010 Financial Results; Provides 2011 Guidance
Date:2/15/2011

gain related to the $30.8 million in antitrust proceeds from Covidien and offset by $14.7 million in marketing and other related expenses that Masimo had previously planned and announced after receiving the proceeds.  Excluding these one-time items, adjusted net income for 2010 was $62.5 million, or $1.03 per diluted share, compared to net income of $53.2 million, or $0.88 per diluted share, in 2009.

During the fourth quarter, the company shipped approximately 41,800 Masimo SET pulse oximetry and Masimo rainbow SET Pulse CO-Oximetry units, excluding handheld units, up 37.5% compared to approximately 30,400 in the same prior year period.  For 2010, Masimo shipped approximately 153,200 Masimo SET pulse oximetry and Masimo rainbow SET Pulse CO-Oximetry units, excluding handheld units, up 37.5% compared to approximately 111,400 in 2009.  Masimo estimates its worldwide installed base as of January 1, 2011 to be 855,000 units, up 18.0% from 724,000 units as of January 2, 2010.Joe Kiani, Chairman and Chief Executive Officer of Masimo, said, "Our strong fourth quarter and fiscal 2010 performance was driven by increasing global demand for our breakthrough Masimo SET and Masimo rainbow SET technologies, allowing us to advance our mission to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications."As of January 1, 2011, cash, cash equivalents and short-term investments totaled $88.3 million, compared to $189.0 million as of January 2, 2010.  The decline was due primarily to special dividend payments of $117.5 million and $44.5 million, made on March 31, 2010 and December 21, 2010, respectively.  Total 2010 dividend payments of $162.0 million were partially offset by the net proceeds from the Covidien antitrust lawsuit and operating cash flow during the year.2011 Financial Guidance Masimo expects fiscal 2011 total revenue to be between $446 million and $463 million, including product re
'/>"/>

SOURCE Masimo Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Mafraq Hospital Becomes First in United Arab Emirates to Deploy Masimo rainbow SET Pulse CO-Oximetry for State-of-the-Art Noninvasive Patient Monitoring
2. Welch Allyn Establishes Strategic Partnership to Incorporate Masimo rainbow® SET Noninvasive Measurement Capabilities in Next-Generation Patient Monitors
3. New Published Study Finds Noninvasive Masimo PVI Accurately Predicts Fluid Responsiveness in Intensive Care Patients
4. Masimo to Report Fourth Quarter and Full Year 2010 Financial Results After Market Close on February 15, 2011
5. Masimo to Present at 29th Annual J.P. Morgan Healthcare Conference
6. New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment
7. Masimo to Present at Piper Jaffray 22nd Annual Healthcare Conference
8. Prime Healthcare Converts System-Wide to Masimo rainbow SET Technology
9. BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States
10. Masimo to Present at Lazard Capital Markets 7th Annual Healthcare Conference
11. Masimo Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 Research ... addition of the "Immunoprotein Diagnostic Testing Market ... the highest CAGR of 6% and is expected ... report to their offering. ... immunoprotein diagnostic testing has been segmented according to ...
(Date:7/11/2014)... July 11, 2014 ... Safety & Health Expo 2014 were a ... to London , plus ... exhibition.          (Logo: ... )      (Photo: ...
(Date:7/10/2014)...  Major advances in radiation therapy and radiosurgery ... in a three-day Oncology Summit taking place in ...  Renowned national and international cancer experts from seven countries ... knowledge on modern technologies making treatment for cancer ... The Summit will address a wide spectrum ...
Breaking Medicine Technology:Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... July 28 HemaQuest Pharmaceuticals, a clinical stage ... disease, beta thalassemia and EBV-related cancers, announced today the ... Series B financing by new investor, Latterell Venture Partners. ... $16M . The financing is intended to help ...
... DIEGO , July 27, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: ... MAC: Management Access Conference in New York on Tuesday, August ... PT .   Alex Casdin , vice president, finance of Amylin ... , , ...
Cached Medicine Technology:HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing 2Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Conference 2010 2
(Date:7/11/2014)... new study challenges the widely held belief that light drinking ... analyzed more than 50 studies that examined drinking habits and ... that those with a form of a gene tied to ... affects how a person,s body breaks down alcohol, resulting in ... variant has been shown to lead to lower drinking over ...
(Date:7/11/2014)... Recent research findings regarding Fourth Phase Water are ... water affects human bodies. That was the conclusion of the ... on the Sharon Kleyne Hour Power of Water radio show ... PhD, is a Professor of Bioengineering at the University of ... (Ebner & Sons, 2013). , “Fourth Phase Water,” ...
(Date:7/11/2014)... Alliance Labs announced that they will ... Ed Begley Jr, airing later this year 2014, via ... this episode, Innovations will explore DocuSol® Kids, a mini-enema ... polyethylene glycol base designed to give adolescents general constipation ... as a hyperosmotic laxative by drawing water into the ...
(Date:7/11/2014)... Re-tearing a repaired knee Anterior Cruciate Ligament ... being presented today at the American Orthopaedic Society for ... identification and patient education regarding modifiable risk factors may ... , “Our research suggests that a few risk factors ... utilized may point to the possibility of re-injury,” said ...
(Date:7/11/2014)... SEATTLE, WA Re-tearing a repaired knee Anterior Cruciate ... study being presented today at the American Orthopaedic Society ... and patient education regarding modifiable risk factors may minimize ... "Our research suggests that a few risk factors such ... may point to the possibility of re-injury," said lead ...
Breaking Medicine News(10 mins):Health News:A Little Alcohol May Not Be Good for Your Heart After All 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 3Health News:Alliance Labs & DocuSol® to be Featured in Upcoming Episode of Innovations 2Health News:New Study May Identify Risk Factors for ACL Re-injury 2
... are soul sisters, says University of Illinois professor Constance ... pregnant and deliver babies that become the center of ... feel defeated and alone. Shapiro,s new book When ... that by providing a sisterhood of survivors who have ...
... more easily diagnosed and that its effects may be more ... in The FASEB Journal ( http://www.fasebj.org ), scientists ... and have discovered that drugs which affect the methylation state ... of drug is already being used in some cancer treatments. ...
... and shampoos, for instance, to breast development, , THURSDAY, ... in a wide range of consumer products may lead ... their risk for health problems later in life, U.S. ... -- phenols, phthalates and phytoestrogens -- are known as ...
... , ... is a great travel booking website for the vacationer who plans in advance, looking for ... a last-minute specials and deals. , ... Los Angeles, CA (PRWEB) April 8, 2010 -- SVH Tours & Travel, a ...
... prescription drugs , THURSDAY, April 8 (HealthDay News) -- Medical ... included -- are poorly informed about herbal medicines and that ... misplaced, according to a new survey. , The survey was ... and Therapeutics Bulletin , which published the results online April ...
... Thomas Mower Sr., Chairman of ... in the growth and success of Sportsmen for Fish and Wildlife (SFW), according to Founder Don ... Salt Lake City (PRWEB) April ... of the Utah Jazz, have been key players in the growth and success of Sportsmen for ...
Cached Medicine News:Health News:The Scarlet I: Infertility survivors lend voices to U of I prof's new book 2Health News:New study of autism reveals a 'DNA tag' (methylation) amenable to treatment 2Health News:Chemicals in Beauty Products Tied to Early Puberty in Girls 2Health News:Agency Pioneer SVH Tours & Travel Launches AppleSpecials.com, New Travel Booking Web Site that Showcases First-Hand Videos and Last Minute Specials 2Health News:Agency Pioneer SVH Tours & Travel Launches AppleSpecials.com, New Travel Booking Web Site that Showcases First-Hand Videos and Last Minute Specials 3Health News:Insight on Herbals Eludes Doctors, Patients Alike 2Health News:Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization 2Health News:Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization 3Health News:Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization 4
Full automatic, ready-to-use strip washer....
MultiWash Advantage is a versatile microplate washer engineered for reliability. It is designed for lab environments to help streamline their daily processes....
Synchron Hemoglobin A1c (HbA1c) utilizes two unique cartridges, Hb and A1c, to determine HbA1c concentration as a percentage of total hemoglobin....
... HbA1c Testing , Monoclonal antibody ... precision , Correlation study shows 99% agreement ... you can count on a CV ... , National Glycohemoglobin Standardization Program (NGSP) certified ...
Medicine Products: